Can a natural supplement soothe an upset stomach?
NCT ID NCT06630455
First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time
Summary
This trial tests whether the dietary supplement Meu-cinn can improve gastric mucosal health and ease symptoms in adults with functional dyspepsia, a condition causing stomach discomfort without a clear cause. Participants will take either Meu-cinn or a placebo daily for 8 weeks. Researchers will measure changes in gastrointestinal symptoms and monitor for side effects to assess the supplement's potential benefit and safety.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Meu-cinn, a dietary supplement
- What this could lead to
- If effective, Meu-cinn could offer a natural option to ease stomach discomfort and improve gastric health in people with functional dyspepsia.
- What could go wrong
- This is an early-stage trial with a modest size, so results may not be conclusive. The supplement's benefits and safety are not yet established, and individual responses may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Rome IV-based functional dyspepsia- Exclusion Criteria: * Patients with gastrointestinal symptoms requiring immediate drug treatment. * Individuals with a history of hypersecretory gastric disorders like Zollinger-Ellison syndrome. * Individuals who received Helicobacter pylori eradication therapy within 4 weeks prior to the trial. * Individuals who have taken nonsteroidal anti-inflammatory drugs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within the last month. * Individuals with a history of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection within the last year. * Individuals with gastric ulcers (active or healing), duodenal ulcers (active or healing), reflux esophagitis (LA grade A or higher), or malignant tumors identified within the last 6 months through endoscopy. * Patients with uncontrolled hypertension (resting BP ≥160/100 mmHg). * Patients with uncontrolled diabetes (fasting glucose ≥160 mg/dL). * Individuals with creatinine levels ≥ 2 times the upper limit of normal at the research institution. * Individuals with aspartate aminotransferase or alanine aminotransferase levels ≥ 2 times the upper limit of normal at the research institution. * Alcohol abusers. * Individuals taking medications for psychiatric disorders (except those taking intermittent medication for sleep disorders). * Pregnant or breastfeeding women or those planning to become pregnant during the clinical trial period. * Individuals with allergies to any components of the study foods. * Individuals who participated in or plan to participate in another drug clinical trial within the last month. * Individuals deemed unsuitable for the study by the investigator for other reasons.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Functioanl dyspepsia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pusan National University Yangsan Hospital
Yangsan, 50612, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.